Figure 8
From: Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation
Rosiglitazone reduces LPS induced NF-κB activity in HTR-8/SVneo cells. HTR8/SVneo cells were stained for co-localizing NF-kB and active Pol II using the proximity ligation assay. (A) Representative images showing colocalization events across the four treatment groups. (B) Graphs shows quantitative analysis for number of co-localization events with increase in the number of events in the LPS treatment group. n = 6, ‘*’,‘ #’ indicates significance at p < 0.05 when compared to the PBS control group and the LPS treated group respectively. Scale bar: 50 µm.
